Evaluation of rhAnnexine V-128 radiolabeled In the Diagnosis of Infectious Endocarditis, the Atrial Thrombus and Their embolic complications associated [Evaluation de la rhAnnexine V-128 radiomarquée Dans le Diagnostic de l'Endocardite Infectieuse, du Thrombus Atrial et de Leurs Complications Emboliques associées]

Trial Profile

Evaluation of rhAnnexine V-128 radiolabeled In the Diagnosis of Infectious Endocarditis, the Atrial Thrombus and Their embolic complications associated [Evaluation de la rhAnnexine V-128 radiomarquée Dans le Diagnostic de l'Endocardite Infectieuse, du Thrombus Atrial et de Leurs Complications Emboliques associées]

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 18 Jul 2016

At a glance

  • Drugs Tc-99m annexin V 128 (Primary)
  • Indications Bacterial endocarditis; Thrombosis
  • Focus Diagnostic use
  • Acronyms AnnIE
  • Most Recent Events

    • 13 Jul 2016 Planned primary completion date changed from 1 Feb 2019 to 1 Sep 2019.
    • 13 Jul 2016 Status changed from not yet recruiting to recruiting.
    • 27 Aug 2015 Planned initiation date changed from 1 Jul 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top